Ahead of US stock trading that day, Moderna and Merck jointly announced the results of the Phase III INTerpath-001 clinical ...
The Chosun Ilbo on MSN
Moderna shares surge 177% on mRNA cancer therapy success
Moderna, a U.S. biotech company, saw its stock price surge 177% in a single day. This spike followed the confirmation of ...
Today, Aug. 19, 2026, Moderna's personalized cancer vaccine met its late-stage goal, with the company and Merck planning an ...
11hon MSN
Merck, Moderna cancer vaccine breakthrough could be catalyst the mRNA ETF trade has been waiting for
Moderna Inc.’s (NASDAQ:MRNA) latest cancer-vaccine breakthrough could be doing more than sending its stock sharply higher. It ...
Moderna and Merck's mRNA cancer vaccine marks a breakthrough in personalized oncology, with broad financial implications for ...
Rumors of an AstraZeneca PLC-Bristol-Myers Squibb Company merger are cooling. Click here for risks and drug portfolio ...
Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are rocketing higher Wednesday morning, with the stock up 93% to $121 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results